CELUW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CINGW
Should you be buying Celularity stock or one of its competitors? The main competitors of Celularity include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Cingulate (CINGW). These companies are all part of the "pharmaceutical products" industry.
Celularity vs.
Celularity (NASDAQ:CELUW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, community ranking, earnings, valuation and media sentiment.
In the previous week, 180 Life Sciences had 1 more articles in the media than Celularity. MarketBeat recorded 2 mentions for 180 Life Sciences and 1 mentions for Celularity. Celularity's average media sentiment score of 1.87 beat 180 Life Sciences' score of 1.24 indicating that Celularity is being referred to more favorably in the media.
Celularity and 180 Life Sciences both received 0 outperform votes by MarketBeat users.
Summary
Celularity beats 180 Life Sciences on 2 of the 3 factors compared between the two stocks.
Get Celularity News Delivered to You Automatically
Sign up to receive the latest news and ratings for CELUW and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CELUW vs. The Competition
Celularity Competitors List
Related Companies and Tools
This page (NASDAQ:CELUW) was last updated on 5/1/2025 by MarketBeat.com Staff
Buy CELUW Stock Free CELUW Stock Alerts